Halozyme Therapeutics
HALO
#2478
Rank
โ‚ฌ5.51 B
Marketcap
43,35ย โ‚ฌ
Share price
-15.40%
Change (1 day)
19.06%
Change (1 year)

Halozyme Therapeutics (HALO) Fails to deliver data

Key failure to deliver metrics for Halozyme Therapeutics:

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for Halozyme Therapeutics (HALO) - 3 months history

Number of shares, 3 months chart

Biweekly Failures to deliver volume for Halozyme Therapeutics (HALO) - since 2013

Volume in USD (price x number of shares), data since 2013

Halozyme Therapeutics (HALO) Failure to deliver volume, Year over Year

Year Volume (Price x Shares) Change
2024โ‚ฌ17.9 M-29.77%
2023โ‚ฌ25.5 M-15.59%
2022โ‚ฌ30.2 M38.39%
2021โ‚ฌ21.82 M-6.23%
2020โ‚ฌ23.27 M-44.23%
2019โ‚ฌ41.74 M591.9%
2018โ‚ฌ6.03 M-64.48%
2017โ‚ฌ16.98 M-5.65%
2016โ‚ฌ17.99 M-13.05%
2015โ‚ฌ20.7 M-7.81%
2014โ‚ฌ22.45 M140.61%
2013โ‚ฌ9.33 M

FTD volume in the last 3 months for similar companies or competitors

Company FTD volume (3 months) FTD volume (1 year) Country
โ‚ฌ0.65 Mโ‚ฌ13.58 M๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ41.73 Mโ‚ฌ0.14 B๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ11.62 Mโ‚ฌ53.13 M๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ50.21 Mโ‚ฌ0.38 B๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ11.64 Mโ‚ฌ71.88 M๐Ÿ‡ซ๐Ÿ‡ท France
โ‚ฌ70.18 Mโ‚ฌ0.32 B๐Ÿ‡บ๐Ÿ‡ธ USA